331 related articles for article (PubMed ID: 19074828)
1. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
Agirre X; Jiménez-Velasco A; San José-Enériz E; Garate L; Bandrés E; Cordeu L; Aparicio O; Saez B; Navarro G; Vilas-Zornoza A; Pérez-Roger I; García-Foncillas J; Torres A; Heiniger A; Calasanz MJ; Fortes P; Román-Gómez J; Prósper F
Mol Cancer Res; 2008 Dec; 6(12):1830-40. PubMed ID: 19074828
[TBL] [Abstract][Full Text] [Related]
2. Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia.
Kronenwett R; Butterweck U; Steidl U; Kliszewski S; Neumann F; Bork S; Blanco ED; Roes N; Gräf T; Brors B; Eils R; Maercker C; Kobbe G; Gattermann N; Haas R
Oncogene; 2005 Aug; 24(34):5313-24. PubMed ID: 15806158
[TBL] [Abstract][Full Text] [Related]
3. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
[TBL] [Abstract][Full Text] [Related]
4. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.
Shi L; Cheng Z; Zhang J; Li R; Zhao P; Fu Z; You Y
Brain Res; 2008 Oct; 1236():185-93. PubMed ID: 18710654
[TBL] [Abstract][Full Text] [Related]
5. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells.
Venturini L; Battmer K; Castoldi M; Schultheis B; Hochhaus A; Muckenthaler MU; Ganser A; Eder M; Scherr M
Blood; 2007 May; 109(10):4399-405. PubMed ID: 17284533
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia modifies proliferation and differentiation of CD34(+) CML cells.
Desplat V; Faucher JL; Mahon FX; Dello Sbarba P; Praloran V; Ivanovic Z
Stem Cells; 2002; 20(4):347-54. PubMed ID: 12110704
[TBL] [Abstract][Full Text] [Related]
7. Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia.
Hussein K; Büsche G; Muth M; Göhring G; Kreipe H; Bock O
Ann Hematol; 2011 Mar; 90(3):307-13. PubMed ID: 20842500
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
[TBL] [Abstract][Full Text] [Related]
9. JNK2 and p38 MAPK over-expressions do not represent key events in chronic myeloid leukemia transformation.
Merkerova M; Bruchova H; Brdicka R
Neoplasma; 2007; 54(6):503-10. PubMed ID: 17949234
[TBL] [Abstract][Full Text] [Related]
10. Linking miRNA regulation to BCR-ABL expression: the next dimension.
Faber J; Gregory RI; Armstrong SA
Cancer Cell; 2008 Jun; 13(6):467-9. PubMed ID: 18538729
[TBL] [Abstract][Full Text] [Related]
11. BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia.
José-Enériz ES; Román-Gómez J; Cordeu L; Ballestar E; Gárate L; Andreu EJ; Isidro I; Guruceaga E; Jiménez-Velasco A; Heiniger A; Torres A; Calasanz MJ; Esteller M; Gutiérrez NC; Rubio A; Pérez-Roger I; Agirre X; Prósper F
Br J Haematol; 2008 Aug; 142(4):571-82. PubMed ID: 18537972
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs play a role in the development of human hematopoietic stem cells.
Liao R; Sun J; Zhang L; Lou G; Chen M; Zhou D; Chen Z; Zhang S
J Cell Biochem; 2008 Jun; 104(3):805-17. PubMed ID: 18189265
[TBL] [Abstract][Full Text] [Related]
13. miR-145 inhibits breast cancer cell growth through RTKN.
Wang S; Bian C; Yang Z; Bo Y; Li J; Zeng L; Zhou H; Zhao RC
Int J Oncol; 2009 May; 34(5):1461-6. PubMed ID: 19360360
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
[TBL] [Abstract][Full Text] [Related]
15. miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation.
Schaar DG; Medina DJ; Moore DF; Strair RK; Ting Y
Exp Hematol; 2009 Feb; 37(2):245-55. PubMed ID: 19135902
[TBL] [Abstract][Full Text] [Related]
16. Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-Abl.
Gutiérrez-Berzal J; Castellano E; Martín-Encabo S; Gutiérrez-Cianca N; Hernández JM; Santos E; Guerrero C
Exp Cell Res; 2006 Apr; 312(6):938-48. PubMed ID: 16443220
[TBL] [Abstract][Full Text] [Related]
17. Human stem cell model to study signal transduction and molecular regulation mechanisms in CML.
Fan E; Hu Y; Zhao C
Chin Med J (Engl); 2001 Jul; 114(7):680-4. PubMed ID: 11780326
[TBL] [Abstract][Full Text] [Related]
18. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
19. Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation.
Wang LL; Zhang Z; Li Q; Yang R; Pei X; Xu Y; Wang J; Zhou SF; Li Y
Hum Reprod; 2009 Mar; 24(3):562-79. PubMed ID: 19091803
[TBL] [Abstract][Full Text] [Related]
20. [Expression analysis of microRNAs in erythropoiesis].
Masaki S; Ohtsuka R; Abe Y; Umemura T
Rinsho Byori; 2008 Dec; 56(12):1086-92. PubMed ID: 19175072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
